Florian Colbatzky

Person

Stafflangen, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Use of inhibitors of the EGFR-mediated signal transduction for the...
- Patent number 8,431,585
- Issue date Apr 30, 2013
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Thomas Singer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dihydropteridinone compounds
- Patent number 8,003,786
- Issue date Aug 23, 2011
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Matthias Hoffmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of Lck inhibitors for treatment of immunologic diseases
- Patent number 7,989,474
- Issue date Aug 2, 2011
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Gerald Juergen Roth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating diseases or conditions using dihydropteridinon...
- Patent number 7,786,299
- Issue date Aug 31, 2010
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Matthias Hoffmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Intermediate compounds for making dihydropteridinones useful as pha...
- Patent number 7,750,152
- Issue date Jul 6, 2010
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Matthias Hoffman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-...
- Patent number 7,189,743
- Issue date Mar 13, 2007
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Norbert Hauel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-...
- Patent number 6,900,229
- Issue date May 31, 2005
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Norbert Hauel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dihydropteridinones, processes for preparing them and their use as...
- Patent number 6,861,422
- Issue date Mar 1, 2005
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Matthias Hoffmann
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Dihydropteridinone Compounds
- Publication number 20100324288
- Publication date Dec 23, 2010
- BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
- Matthias HOFFMANN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF INHIBITORS OF THE EGFR-MEDIATED SIGNAL TRANSDUCTION FOR THE...
- Publication number 20100144639
- Publication date Jun 10, 2010
- BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
- Thomas Singer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Lck inhibitors for treatment of immunologic diseases
- Publication number 20090306104
- Publication date Dec 10, 2009
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Gerald Juergen Roth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Lck inhibitors for treatment of immunologic diseases
- Publication number 20090087405
- Publication date Apr 2, 2009
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Gerald Juergen ROTH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Piperazinyl Compounds
- Publication number 20080293944
- Publication date Nov 27, 2008
- Matthias Hoffmann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Intermediate Compounds for making Dihydropteridinones Useful as Pha...
- Publication number 20080171747
- Publication date Jul 17, 2008
- Matthias Hoffman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Use of inhibitors of the EGFR-mediated signal transduction for the...
- Publication number 20070099918
- Publication date May 3, 2007
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Thomas Singer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for treating diseases or conditions using dihydropteridinon...
- Publication number 20060025411
- Publication date Feb 2, 2006
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Matthias Hoffmann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-...
- Publication number 20050137233
- Publication date Jun 23, 2005
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Norbert Hauel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Intermediate compounds for making dihydropteridinones useful as pha...
- Publication number 20050014761
- Publication date Jan 20, 2005
- Boehringer Ingelheim Pharma Gmbh & Co. KG
- Matthias Hoffmann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods of treating diseases or conditions using dihydropteridinone...
- Publication number 20050014760
- Publication date Jan 20, 2005
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Matthias Hoffmann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Use of Lck inhibitors for treatment of immunologic diseases
- Publication number 20040204458
- Publication date Oct 14, 2004
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Gerald Juergen Roth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
New dihydropteridinones, processes for preparing them and their use...
- Publication number 20040176380
- Publication date Sep 9, 2004
- Boehringer Ingelheim Pharma GmbH Co. KG
- Matthias Hoffmann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-...
- Publication number 20040059118
- Publication date Mar 25, 2004
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Norbert Hauel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Use of inhibitors of the EGFR-mediated signal transduction for the...
- Publication number 20030225079
- Publication date Dec 4, 2003
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Thomas Singer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Florian Colbatzky

Person

Patents Grantslast 30 patents

Use of inhibitors of the EGFR-mediated signal transduction for the...

Dihydropteridinone compounds

Use of Lck inhibitors for treatment of immunologic diseases

Methods for treating diseases or conditions using dihydropteridinon...

Intermediate compounds for making dihydropteridinones useful as pha...

Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-...

Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-...

Dihydropteridinones, processes for preparing them and their use as...

Patents Applicationslast 30 patents

Dihydropteridinone Compounds

USE OF INHIBITORS OF THE EGFR-MEDIATED SIGNAL TRANSDUCTION FOR THE...

Use of Lck inhibitors for treatment of immunologic diseases

Use of Lck inhibitors for treatment of immunologic diseases

Piperazinyl Compounds

Intermediate Compounds for making Dihydropteridinones Useful as Pha...

Use of inhibitors of the EGFR-mediated signal transduction for the...

Methods for treating diseases or conditions using dihydropteridinon...

Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-...

Intermediate compounds for making dihydropteridinones useful as pha...

Methods of treating diseases or conditions using dihydropteridinone...

Use of Lck inhibitors for treatment of immunologic diseases

New dihydropteridinones, processes for preparing them and their use...

Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-...

Use of inhibitors of the EGFR-mediated signal transduction for the...